M. Digiovanni

Phospho-valproic acid (MDC-1112) reduces pancreatic cancer growth in patient-derived tumor xenografts and KPC mice: enhanced efficacy when combined with gemcitabine.

B. Rigas, Joseph F LaComb, G. Mackenzie, 2019, Carcinogenesis.

A novel tricarbonylmethane agent (CMC2.24) reduces human pancreatic tumor growth in mice by targeting Ras

L. Golub, Joseph F LaComb, M. Nemesure, 2018, Molecular carcinogenesis.

RANDOMIZED CONTROLLED TRIAL OF STREPTOKINASE, ASPIRIN, AND COMBINATION OF BOTH IN TREATMENT OF ACUTE ISCHEMIC STROKE

L. Munari, G. Lancia, R. Peto, 1995 .